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The aim of this study was to see how a mixture of cadmium (Cd) and decabrominated diphenyl ether 
(BDE209) affect thyroid function, namely thyroid-stimulating hormone (TSH), thyroxin (T4), free thyroxin 
(FT4), triiodothyronin (T3), and free triiodothyronin (FT3) in Wistar rats (eight per group) receiving either 
a single substance or their combination by gavage for 28 days. Three groups were receiving Cd alone in 
the doses of 2.5 mg kg-1, 7.5 mg kg-1, or 15 mg kg-1 b. w. a day, three groups were receiving BDE209 in 
the doses of 1000 mg kg-1, 2000 mg kg-1, or 4000 mg kg-1 b. w. a day, while nine groups were receiving 
different mixtures of Cd and BDE209 in these doses (3x3 design). The results have indicated that the 
Cd+BDE209 mixtures more potently disrupt thyroid hormone homeostasis than would be expected from 
these chemicals alone.
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Chemical risk assessment procedures commonly 
rely on determining the effects of a single substance. 
Over the last decade, however, a number of well-
designed studies have investigated the effects of 
multi-component mixtures (1-4). High-level exposure 
to cadmium (Cd) is usually a result of environmental 
contamination due to various anthropogenic activities 
(5, 6). Acute or chronic exposure to Cd can affect the 
liver, kidney, bone, and testes in humans and 
experimental animals (7-13). In addition, there is 
evidence that Cd can alter thyroid function (6, 14-
17).
Flame retardants have also become very important 
environmental and occupational pollutants. Through 
history, BDE209 was thought to be released minimally 
into the environment during all phases of its use and 
not available biologically due to its large molecular 
size and low aqueous solubility. However, today it is 
a widespread environmental contaminant with 
evidence demonstrating its bioaccumulation and toxic 
potential (18-23). Recent studies with polybrominated 
diphenyl ethers (PBDEs) have shown that they disturb 
liver enzyme activity and thyroid hormone function 
(24-29), reduce epididymal sperm function (30), and 
may affect the nervous system and newborns (31, 
32). 
Cadmium and BDE209 are jointly present in the 
environmental media, food, biota, and human tissues 
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through several pathways as a result of emission from 
various sources. Combined exposure to Cd and organic 
pollutants may result in complex toxicity. In view of 
the importance of in vivo behaviour of contaminants 
concomitantly present in an organism, this study was 
aimed at determining the effects of mixtures of Cd 
and BDE209 on thyroid-stimulating hormone (TSH), 
thyroxin (T4), free thyroxin (FT4), triiodothyronin 
(T3), and free triiodothyronin (FT3) in rats.
MATERIALS AND METHODS
Experimental animals
Male albino Wistar rats weighing 200 g to 240 g 
were obtained from a disease-free stock bred at the 
Military Medical Academy in Belgrade, Serbia. The 
animals were housed in plastic cages with a plastic 
bottom and wire mesh top, in a climate-controlled 
facility with a constant 12-hour day and night cycle 
at 20 °C to 24 °C and relative humidity between 40 % 
and 60 %. The animals had free access to food and tap 
water throughout the study and were treated according 
to the guidelines for animal studies (no. 9667-1/2011) 
issued by the Academy’s ethics committee.
After a quarantine period of 14 days, groups of 
eight animals each were receiving either a single 
substance or their combinations by gavage in a volume 
of 0.5 mL kg-1 b.w. per day for 28 days. Three groups 
were receiving Cd alone in the form of CdCl2 x H2O 
(Merck, Darmastadt, Germany) in the doses of 
2.5 mg kg-1, 7.5 mg kg-1, or 15 mg kg-1 b. w. per day 
(Cd2.5, Cd7.5, and Cd15, respectively) and three groups 
BDE 209 alone as a suspension in dimethyl sulphoxide 
(DMSO, Sigma-Aldrich, St. Louis, MO, USA) in the 
doses of 1000 mg kg-1, 2000 mg kg-1, or 4000 mg kg-1 
b. w. per day (BDE2091000, BDE2092000, and BDE2094000, 
respectively). Cadmium doses were selected to reﬂ ect 
environmental to occupational exposure (7, 9, 16). 
The choice of BDE209 doses was based on literature 
data on its very low absorption rate of 0.3 % to 2 % 
(18, 19). The remaining nine groups were receiving 
combinations of Cd and BDE209 doses according to 
the 3x3 design. 
Before gavage Cd salt and BDE209 were dissolved 
in DMSO.
Rats in the vehicle control group were receiving 
DMSO alone (DMSO group), while control animals 
were receiving saline (control group).
We did our best to minimise the suffering and the 
number of animals used. Throughout the study, the 
rats were continuously monitored for body weight, 
clinical signs such as changes in the skin, fur, eyes, 
mucous membranes, secretions and excretions, 
autonomic activity (lacrimation, piloerection, pupil 
size, unusual respiratory patterns), behaviour, and food 
and water intake. Signs of toxicity were monitored on 
a daily basis, while water and food intake were 
recorded weekly. After decapitation, blood was 
collected from the carotid arteries in glass tubes and 
then centrifuged at 3000×g for 30 min. The supernatant 
(serum) was transferred to polypropylene test tubes 
and stored at −70 °C until thyroid hormone analysis.
Hormone analysis
Serum samples were analysed for thyroid-
stimulating hormone, thyroxin, triiodothyronin, and 
free triiodothyronin with commercial tests using a 
Roche Elecsys 2010 analyser (Roche Diagnostics, 
Mannheim, Germany). Values for T3 and T4 are 
expressed as nmol L-1, for FT3 and FT4 as pmol L-1 
while for TSH as mU L-1. The analytical ranges were 
0.005 mU L-1 to 100 mU L-1 for TSH, 0.30 nmol L-1 
to 10 nmol L-1 for T3, 5.40 nmol L-1 to 320 nmol L-1 
for T4, 0.40 pmol L-1 to 50 pmol L-1 for FT3, and 
0.30 pmol L-1 to 100 pmol L-1 for FT4. Total precisions 
over these ranges (expressed as coefficients of 
variance) were 5.4 % for TSH, 4.8 % for T3, 3.3 % 
for T4, 2.2 % for FT3, and 2.7 % for FT4.
Statistical analysis
To establish signiﬁ cance of differences between the 
groups, we used one-way analysis of variance (ANOVA) 
and subsequently Tukey’s paired comparisons or 
Fisher’s least signiﬁ cant difference (LSD) as post hoc 
tests. The level of statistical signiﬁ cance for all tests 
was set at p<0.05. All data were analysed using the 
statistical package Statistica 7.0.
RESULTS
Slower body weight gain was the most common 
in groups treated with the combination of compounds 
(in eight out of nine groups), while Cd or BDE209 
alone did not cause signiﬁ cant changes compared to 
controls (Table 1). However, water and food 
consumption did not differ significantly between 
animals receiving single compounds (Cd or BDE209) 
and animals receiving their combinations.
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Food consumption was lower in all groups 
compared to control, and the Cd15 group also showed 
a signiﬁ cant decrease compared to the DMSO group 
(Table 1). Groups treated with combinations did not 
differ in food consumption from groups treated with 
Cd or BDE209 alone. Water consumption decreased 
in all groups compared to control, with the exception 
of the Cd7.5+BDE2092000 group. Compared to the 
DMSO group, only the Cd7.5 and the BDE2094000 
groups showed lower water consumption, and the 
same effect was observed in the following four 
combination groups: Cd7.5 or Cd15+BDE2091000, 
Cd15+BDE2092000 and Cd7.5+BDE2094000. The only 
statistically significant difference between the 
combination groups and corresponding single-
compound groups was noticed for the Cd15+BDE2092000 
vs. BDE2092000 group; the ﬁ rst drank about 30 % less 
water than the BDE2092000 group. Decreases in food 
and water intake of almost 50 % in some groups are 
in accordance with lower body weight gain. Except 
for food and water intake and body weight gain, there 
were no other clinical signs of poisoning.
All three Cd doses induced a signiﬁ cant decrease 
in T4 and FT4 levels vs. control, whereas 2.5 mg kg-1 
Cd led to a decrease in FT3 and 15 mg kg-1 Cd to 
decrease in T3 and FT3 levels (Table 2). Signiﬁ cant 
differences from the DMSO group were seen in the 
Cd2.5 (FT4), Cd7.5 (FT3, T4), and Cd15 (FT3) groups. 
Similar to Cd alone, all three doses of BDE209 
induced a signiﬁ cant decrease in T4 and FT4 levels 
vs. control. Compared to the DMSO group, a 
significant decrease in hormone levels, given in 
brackets, was observed in the BDE2091000 (FT3, T4), 
BDE2092000 (FT3, T4, FT4), and BDE2094000 (T3) 
groups.
Table 1  Body weight and food and water intake in Wistar rats orally exposed to BDE209, Cd, or their combinations for 28 
days.
Body weight / g Daily consumption
Group Final Gain Food / g Water / mL
Control 312.50±5.01 115.7±9.04 40.75±1.50 73.25±5.32
DMSO 300.04±14.14 85.00±19.15 30.00±8.89 53.00±14.61
Cd2.5 331.25±24.16 107.50±26.05 24.51±2.33a 45.66±2.37a
Cd7.5 290.00±52.15 80.00±31.62 20.03±3.15a 36.35±3.08a,b
Cd15 304.29±20.70 82.86±24.98a 17.51±3.38a,b 37.53±5.66a
BDE2091000 317.50±19.08 113.80±16.85b 22.92±4.02a 44.58±12.58a
BDE2092000 305.00±18.71 88.00±10.95a 25.00±5.47a 41.68±16.01a
BDE2094000 291.67±48.75 84.00±25.10a 27.08±1.58a 43.77±4.15a,b
Cd2.5+BDE2091000 286.25±27.74 81.30±26.96a,c,d 21.56±4.72a 34.37±11.38a
Cd7.5+BDE2091000 258.33±41.19 20.00±1.41a,b,c,d 18.30±11.03a 30.45±15.28a,b
Cd15+BDE2091000 261.43±48.11 66.67±30.77a,d 23.84±5.55a 32.41±10.53a,b
Cd2.5+BDE2092000 243.33±30.11 26.00±8.94a,b,c,d 18.75±12.58a 26.25±18.33a
Cd7.5+BDE2092000 270.00±24.49 71.67±20.41a 22.08±5.49a 50.42±22.14
Cd15+BDE2092000 215.00±8.37 20.00±7.07a,b,c,d 16.48±7.69a 29.15±4.79a,b,d
Cd2.5+BDE2094000 250.01±38.47 22.50±8.25a,b,c,d 20.82±5.19a 45.85±4.79a
Cd7.5+BDE2094000 228.00±10.95 30.00±10.95a,b,c,d 19.57±4.17a 41.28±0.85a,b
Cd15+BDE2094000 232.00±21.68 57.50±23.63a,d 20.82±3.21a 33.75±11.15a
Cd2.5, Cd7.5, and Cd15- receiving Cd alone in a daily dose of 2.5 mg kg-1, 7.5 mg kg-1 or 15 mg kg-1 b. w., respectively
BDE2091000, BDE2092000, and BDE2094000 - receiving BDE209 alone in a daily dose of 1000 mg kg-1, 2000 mg kg-1, or 4000 mg kg-1 
b. w., respectively
a - signiﬁ cantly different from control; b - signiﬁ cantly different from the DMSO group; c - signiﬁ cantly different from the same 
Cd dose; d – signiﬁ cantly different from the same BDE209 dose (one way ANOVA and post-hoc Fisher’s Least Signiﬁ cant 
Difference (LSD) test, p<0.05).
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Combinations added to these effects, particularly 
in the groups receiving BDE209 (1000 mg kg-1 or 
2000 mg kg-1) plus Cd (all three doses). Cd+BDE209 
(1000 mg kg-1) signiﬁ cantly decreased T4 and FT4 
levels compared to the groups given the corresponding 
doses of either Cd or BDE209. BDE209 (2000 mg 
kg-1) plus Cd also signiﬁ cantly decreased T4 and FT4, 
and additionally T3 levels. We measured TSH levels 
as well, but they were all below the limit of detection 
(0.005 mU L-1).
Statistical analysis of the ratio between T3 and T4 
pointed out that it was signiﬁ cantly higher in almost 
all groups compared to control. In the Cd7.5 group and 
in the groups receiving combinations Cd2.5+BDE2091000 
and Cd2.5+BDE2092000 this ratio was also signiﬁ cantly 
higher than in the DMSO group. All Cd combinations 
with the highest dose of BDE209 also showed a 
significant increase in respect to treatment with 
corresponding dose of BDE209 alone. Expressed in 
percentages, the ratio between T3 and T4 varied from 
5 % to 27 %, while in groups Cd+BDE2094000 it varied 
from 10 % to 18 %, compared to the DMSO group.
DISCUSSION
Both pollutants, alone or in combination lowered 
thyroid hormone levels compared to control, but the 
combined effect was more pronounced. The combined 
effect on the levels of T3, FT3, T4, and FT4 may be 
viewed as additive. A number of studies have already 
shown that Cd alters thyroid function in experimental 
Table 2 Serum thyroid hormone levels in Wistar rats orally exposed to Cd, BDE209, or their combinations for 28 days
Thyroid hormone levels Ratio
Group T3 / nmol L-1 FT3 / pmol L-1 T4 / nmol L-1 FT4 / pmol L-1 T3/T4
Control 1.52±0.06 4.57±0.19 82.66±3.36 42.51±2.22 0.0183
DMSO 1.46±0.05 4.37±0.33 62.93±4.45a 32.85±4.18a 0.0232 
Cd2.5 1.40±0.13 3.29±0.24a 54.66±4.11a 27.88±3.15a,b 0.0256a 
Cd7.5 1.40±0.15 3.69±0.45b 47.43±9.04a,b 23.84±3.60a 0.0295a,b 
Cd15 1.34±0.10a 3.56±0.25a,b 54.90±4.40a 29.44±2.65a 0.0244a
BDE2091000 1.39±0.06a 2.98±0.87a,b 53.84±5.51a,b 31.02±2.88a 0.0258a 
BDE2092000 1.44±0.09 4.72±0.73b 49.61±6.77a,b 25.31±3.31a,b 0.0290a 
BDE2094000 1.30±0.12a,b 4.38±0.79 61.85±8.02a 29.82±3.82a 0.0210
Cd2.5+BDE2091000 1.34±0.05a 3.33±0.17a 47.48±4.04a,b,c 24.15±3.00a,b,c,d 0.0282a,b
Cd7.5+BDE2091000 1.38±0.06a 4.01±0.20 64.48±4.12a,c,d 31.00±3.36a,b,c 0.0214
Cd15+BDE2091000 1.30±0.05a,b 3.22±0.31a,b 47.78±7.74a,b,c 24.32±2.28a,b,c,d 0.0272a
Cd2.5+BDE2092000 1.28±0.14a,b,c,d 4.09±0.50c 43.46±5.42a,b,c 22.31±2.49a,b,c 0.0295a,b
Cd7.5+BDE2092000 1.27±0.12a,b,c,d 3.81±0.53d 47.43±7.58a,c,d 25.32±3.62a,b 0.0268a
Cd15+BDE2092000 1.22±0.17a,b,c,d 3.83±0.33d 47.13±8.58a,b,c 24.29±3.27a,b,c 0.0259a
Cd2.5+BDE2094000 1.31±0.15a,b 3.94±0.49c 51.41±14.21a,b,d 28.11±5.22a,b 0.0255a,d
Cd7.5+BDE2094000 1.32±0.14a,b 4.09±0.26 48.11±4.60a,b 23.90±2.22a,d 0.0274a,d
Cd15+BDE2094000 1.43±0.10 4.52±0.53c 54.15±7.65a,b 29.03±4.15a 0.0264 a,d 
Cd2.5, Cd7.5, and Cd15- receiving Cd alone in a daily dose of 2.5 mg kg-1, 7.5 mg kg-1 or 15 mg kg-1 b. w., respectively
BDE2091000, BDE2092000, and BDE2094000 - receiving BDE209 alone in a daily dose of 1000 mg kg-1, 2000 mg kg-1, or 4000 mg kg-1 
b. w., respectively
a - signiﬁ cantly different from control; b - signiﬁ cantly different from the DMSO group; c - signiﬁ cantly different from the same 
Cd dose; d – signiﬁ cantly different from the same BDE209 dose (one way ANOVA and post-hoc Fisher’s Least Signiﬁ cant 
Difference (LSD) test, p<0.05).
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animals (6, 7, 9, 14, 15-17, 33) and humans (34). 
Yoshizuka et al. (17) suggested that Cd accumulated 
in the mitochondria of thyroid follicular epithelial cells 
might disturb the oxidative phosphorylation of this 
organelle, lower energy supply, and therefore inhibit 
the synthesis and release of thyroid hormones. 
Similarly, Pilat-Marcinkiewicz et al. (16) observed a 
dose-dependent effect on the structure and function 
of thyroid follicular cells in rats. Apart from the studies 
suggesting that Cd interferes with the thyroid function 
at the glandular level, there are ﬁ ndings supporting 
the effects at the peripheral level by inhibiting the 
conversion of T4 to T3 (14, 35-38). Thyroid hormones 
are metabolised in peripheral tissue by deiodination, 
conjugation, deamination, and decarboxylation 
enzyme reactions, and any change in these metabolic 
pathways may signiﬁ cantly affect thyroid function at 
the cellular level (35-37). As deiodination of T4 to T3, 
which occurs mainly in the liver, depends on 5′-
monodeiodinase activity (35, 37), hepatic dysfunction 
is likely to affect thyroid hormone levels (36), T3 in 
particular. However, thyroid hormone levels are 
mainly regulated by the hypothalamic-pituitary-
thyroid axis and if this axis is affected by Cd, so will 
hormone release (39, 40).
Several reports have shown that a broad range of 
chemicals to which humans are routinely and 
inadvertently exposed can bind to thyroid receptors 
(TRs) and may produce complex effects on thyroid 
hormone signalling (41-43). Polybrominated 
diphenylethers, structurally related to BDE209, have 
been also recognised to bind to TRs and perhaps mimic 
thyroid hormones (42, 43). We may therefore assume 
that BDE209 binds to thyroid receptors rather than 
acts through the hypothalamic-pituitary axis. However, 
Zhou et al. (28) found that decaBDE caused no 
changes in any of the thyroid hormone levels (28). In 
contrast, Kim et al. (44) found signiﬁ cant increases in 
thyroid weight of pregnant rats exposed to high doses 
of BDE209 and signiﬁ cantly lower concentrations of 
T4 in F1 female offspring exposed to BDE209 on 
postnatal day 42. In a recent study, Lee et al. (22), 
found signiﬁ cantly lower total serum T3 concentrations, 
degenerated follicular epithelium, and hepatocyte 
hypertrophy and vacuolisation in newborn rats 
exposed to BDE209. These ﬁ ndings conﬁ rm that 
BDE209 might affect thyroid hormone synthesis and 
metabolism.
The combination of Cd and BDE209 toxicity has 
even more pronounced effects on T3 and T4, which 
can be explained by different mechanisms of their 
action. Although, we assumed additive response, 
future studies should look into the type of interactions 
between Cd and BDE209 at dose levels relevant for 
human exposure.
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Sažetak
KOMBINIRANO DJELOVANJE KADMIJA I DEKABROMIRANOG DIFENIL ETERA NA HORMONE 
ŠTITNJAČE U ŠTAKORA
Cilj ovoga istraživanja bio je utvrditi na koji način smjesa kadmija (Cd) i dekabromiranog difenil etera 
(BDE209) djeluje na aktivnost štitnjače. Određivane su aktivnosti stimulirajućega hormona štitnjače (TSH), 
tiroksina (T4), slobodnog tiroksina (FT4), trijodtironina (T3) te slobodnog trijodtironina (FT3) kao 
parametara koji upućuju na funkcionalnost štitnjače. Kao eksperimentalni testni sustav korišteni su Wistar 
štakori (n=8 po grupi), kojima je tijekom 28 dana dozirana pojedinačna tvar ili smjesa kadmija i 
dekabromiranog difeniletera. Životinje su bile podijeljene u tri grupe koje su primale tri različite doze 
kadmija: 2,5 mg kg-1, 7,5 mg kg-1 i 15 mg kg-1 tjelesne težine po danu. Tri grupe životinja primale su tri 
različite doze BDE209: 1000 mg kg-1, 2000 mg kg-1, odnosno 4000 mg kg-1 tjelesne težine po danu. Preostale 
životinje bile su podijeljene u devet grupa kojima su bile dozirane različite koncentracije kadmija i 
dekabromiranog difenil etera (3x3 dizajn). Rezultati pokazuju da Cd+BDE209 smjesa u većoj mjeri remeti 
homeostazu hormona štitnjače u odnosu na pojedinačne spojeve.
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